Gender Reassignment Surgery Market Report 2026

The gender reassignment surgery market size has grown strongly in recent years. It will grow from $1.93 billion in 2025 to $2.11 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing recognition of gender dysphoria, expansion of specialized surgical expertise, growing acceptance of gender-affirming healthcare, availability of advanced surgical techniques, rising awareness through advocacy and education.

The gender reassignment surgery market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for gender-affirming healthcare services, rising investments in specialized surgical infrastructure, expansion of insurance coverage for procedures, growing adoption of advanced surgical technologies, increasing focus on multidisciplinary care models. Major trends in the forecast period include increasing adoption of minimally invasive surgical techniques, rising use of robotic-assisted gender-affirming surgeries, growing focus on comprehensive gender-affirming care pathways, expansion of specialized surgical centers, enhanced emphasis on patient safety and outcomes.

The rising number of transgender and non-binary individuals is expected to drive the growth of the gender reassignment surgery market going forward. Transgender and non-binary individuals are those whose gender identity does not correspond with the sex assigned at birth, with non-binary individuals identifying beyond traditional male and female categories. The increase in transgender and non-binary populations is largely driven by growing societal awareness and acceptance, empowering more people to live openly according to their true gender identity. Gender reassignment surgery benefits transgender and non-binary individuals by aligning their physical characteristics with their gender identity, thereby improving mental health, self-esteem, and overall quality of life. For instance, in February 2025, according to a report by USAFacts, a US-based nonpartisan research organization, approximately 0.95% of U.S. adults identified as transgender, based on Household Pulse Survey data collected from May to September 2024. Most adults (97.35%) identified as cisgender, while 1.70% identified as neither male, female, nor transgender, instead using terms such as "non-binary," "intersex," or "gender non-conforming." Therefore, the rising number of transgender and non-binary individuals is driving the growth of the gender reassignment surgery market.

The growing demand for personalized healthcare is also expected to propel the growth of the gender reassignment surgery market. Personalized healthcare refers to medical care that is tailored to an individual’s genetic makeup, lifestyle, and environmental factors. The rise in personalized healthcare is largely due to advances in genetic testing, which enable more accurate diagnoses and customized treatment plans. Personalized healthcare supports gender reassignment surgery by providing care plans adapted to each person’s hormonal balance, psychological well-being, and overall health, enhancing safety and outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 personalized therapies in 2023 aimed at treating rare diseases, up from six such approvals in 2022. Therefore, the growing demand for personalized healthcare is driving the growth of the gender reassignment surgery market.

Major companies in the gender reassignment surgery market are focusing on developing innovative solutions, such as integrated care centers, to provide comprehensive and culturally competent care for transgender individuals. Integrated care centers are facilities that offer medical, mental health, and social support services under one roof to ensure coordinated and holistic care. For instance, in March 2023, Mount Sinai Health System, a US-based academic medical institution, launched the Center for Transgender Medicine and Surgery. The center provides a full range of services, including hormone therapy, surgical care, mental health support, and primary healthcare, delivered by a single multidisciplinary team. This approach enhances transgender healthcare by consolidating previously scattered services into a cohesive, accessible model. It also incorporates inclusive intake procedures, specialized staff training, and data-informed practices to optimize the quality and effectiveness of care within a major urban hospital system.

Major companies operating in the gender reassignment surgery market are Kaiser Permanente, The Regents Of The University Of California, Mayo Clinic, Cleveland Clinic, New York Presbyterian Hospital, Cedars Sinai Medical Centre, Vancouver Coastal Health, Mount Sinai Hospital, Boston Medical Center Corporation, Sheba Medical Center, Ghent University Hospital, Rochester Regional Health System, Chettawut Plastic Surgery Center, GRS Montreal Inc, Moein Surgical Arts, Phuket Plastic Surgery Institute, Regents Of The University Of Michigan, Rumer Cosmetic Surgery, Sava Perovic Foundation Surgery, The London Transgender Clinic, CNY Cosmetic And Reconstructive Surgery, IM Gender Clinic.

North America was the largest region in the gender reassignment surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gender reassignment surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gender reassignment surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the gender reassignment surgery market by increasing costs of imported surgical instruments, robotic systems, medical devices, and specialized implants used in complex procedures. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported advanced surgical equipment, while Asia-Pacific faces higher procurement costs for robotic platforms. These tariffs are contributing to higher procedural costs and capital expenditure. However, they are also encouraging local manufacturing of surgical tools and broader adoption of cost-efficient surgical technologies.

The gender reassignment surgery market research report is one of a series of new reports that provides gender reassignment surgery market statistics, including gender reassignment surgery industry global market size, regional shares, competitors with a gender reassignment surgery market share, detailed gender reassignment surgery market segments, market trends and opportunities, and any further data you may need to thrive in the gender reassignment surgery industry. This gender reassignment surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Gender reassignment surgery refers to a set of surgical procedures performed to align an individual's physical sexual characteristics with their gender identity, typically involving the reconstruction or modification of genitalia, chest, and other anatomical features to support gender transition. It is commonly utilized by individuals diagnosed with gender dysphoria as part of a broader gender-affirming healthcare process.

The primary types of gender reassignment surgeries are male-to-female and female-to-male. Male-to-female gender reassignment surgery involves altering male anatomical structures to create female physical characteristics, typically as part of gender-affirming treatment for transgender women. The technologies used in these surgeries include minimally invasive techniques, robotic-assisted surgery, and traditional open surgery, and they are delivered through channels such as public healthcare systems and private healthcare providers. These procedures are utilized by end users including hospitals, specialty clinics, and ambulatory surgical centers (ASCs).

The gender reassignment surgery market consists of revenues earned by entities by providing services such as perineoplasty, mons pubis reshaping, labia majora augmentation, and urethroplasty. The market value includes the value of related goods sold by the service provider or included within the service offering. The gender reassignment surgery market also includes sales of hormone replacement therapy medications, compression garments, hair removal devices, and transplant devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.